News

The Max Planck Florida Foundation today announced that Gunster, one of Florida’s oldest and largest business law firms, will underwrite the construction of a conference room in the Max Planck Florida Institute’s (MPFI) new 100,000-sq.-ft. biomedical research facility on Florida Atlantic University’s MacArthur campus in Jupiter. The new building, which is scheduled to open this summer, is designed to accommodate nearly 58,000-sq.-ft. of laboratory space, three research wings and a 100-seat auditorium. The Institute is currently 

The Max Planck Florida Foundation today announced that Palm Beach residents Howard and Pat Lester have made a significant donation through the David Minkin Foundation to name the lobby of the Max Planck Florida Institute’s (MPFI’s) new 100,000-sq.-ft. biomedical research facility on Florida Atlantic University’s MacArthur campus in Jupiter. With the new building scheduled to open in June 2012, MPFI is currently operating

BOCA RATON, FLORIDA--(Marketwire - March 15, 2012) - Allezoe Medical Holdings (OTCBB:ALZM) today announced that Caroline Pinell has agreed to join the Company on a full time basis and has been named as the President and

JUPITER, Fla. (March 15, 2012) --- The Max Planck Florida Institute (MPFI) and the International Brain Research Organization (IBRO) recently hosted a two-day scientific symposium, “Neural Circuits: From Molecules to Behavior”

Dyadic International, Inc. ("Dyadic") (otc pink:DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and

Two of South Florida’s most prominent private and nonprofit biotechnology organizations are teaming up as Opko Health signed a deal with the Scripps Research Institute in Jupiter for the commercial development of a potential Parkinson’s disease treatment.

The Miami-based company (NYSE: OPK) is led by Chairman and CEO Phillip Frost, a trustee at Scripps and a big donor to the research organization.

JUPITER, Fla. (March 7, 2012) – The Max Planck Florida Institute (MPFI) announced today that Duke University neuroscientist Ryohei Yasuda, PhD will join the Institute as Scientific Director of the Neuronal Signal Transduction Research Group. Dr. Yasuda will be the third Scientific Director for the Institute, joining CEO David Fitzpatrick, PhD and Nobel laureate Bert Sakmann, MD, PhD in this role, which provides unparalleled long-term research support and scientific freedom.  Dr. Yasuda’s appointment was announced during the inaugural MPFI-International Brain Research Organization (IBRO) scientific symposium, “Neural Circuits: From Molecules to Behavior,” at which he spoke.

The Florida Cleantech Acceleration Network Program (FL-CAN) has collaborated with universities within the State University System of Florida to produce an extensive list of laboratory facilities geared towards cleantech industries.